Down-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes

doi:10.4239/wjd.v4.i6.263

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7999)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

608

WORD

347

HTML

4940

Figures (1-4)

454

Sum=6349

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

848

Download

802

Sum=1650

Dec 15, 2013 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Diabetes. Dec 15, 2013; 4(6): 263-269
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.263

Full Size Figure Download Figure

Figure 3 A role of incretin signaling in pancreatic β-cells. Incretins (GLP-1 and GIP) bind their incretin receptors (GLP-1 and GIP receptors) in β-cells and increase intracellular cAMP levels, leading to stimulation of insulin secretion, suppression of β-cell apoptosis and increase of β-cell growth.

Citation: Kaneto H, Matsuoka TA. Down-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes. World J Diabetes 2013; 4(6): 263-269
URL: https://www.wjgnet.com/1948-9358/full/v4/i6/263.htm
DOI: https://dx.doi.org/10.4239/wjd.v4.i6.263